Cost-effectiveness of triplet therapies in metastatic hormone-sensitive prostate cancer used in PEACE-1 and ARASENS

被引：0
|
作者：
Lester-Coll, Nataniel Hernan
Benjamin, David Joseph
Ribault, Helene
Foulon, Stephanie
Fizazi, Karim
Rezazadeh, Arash
机构：
[1] Univ Vermont, Larner Coll Med, Burlington, VT USA
[2] Hoag Family Canc Inst, Newport Beach, CA USA
[3] Unicancer, Paris, France
[4] Gustave Roussy Inst, Villejuif, France
[5] Univ Paris Saclay, Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Univ Calif Irvine, Div Hematol Oncol, Orange, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
222
引用
收藏
页码：222 / 222
页数：1
相关论文
共 50 条
  • [31] ARASENS: A phase 3 trial of darolutamide in combination with docetaxel for men with metastatic hormone-sensitive prostate cancer (mHSPC).
    Smith, Matthew Raymond
    Saad, Fred
    Hussain, Maha
    Sternberg, Cora N.
    Fizazi, Karim
    Yamada, Karin Sayuri
    Kappeler, Christian
    Kuss, Iris
    Tombal, Bertrand F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer
    Wu, Huina
    Sun, Lei
    Feng, Rui
    Zhang, Huiyue
    Tang, Ke
    Wang, Shuo
    Nie, Jing
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [33] Novel androgen axis systemic therapies for metastatic hormone-sensitive prostate cancer
    Hahn, Andrew W.
    Hale, Peter
    Rathi, Nityam
    Agarwal, Neeraj
    CURRENT OPINION IN UROLOGY, 2017, 27 (06) : 559 - 565
  • [34] Rezvilutamide for metastatic hormone-sensitive prostate cancer
    Ye, Dingwei
    Gu, Weijie
    Li, Junliang
    LANCET ONCOLOGY, 2022, 23 (11): : E491 - E491
  • [35] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [36] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Bernard, Brandon
    Sweeney, Christopher J.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [37] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [38] Management of Metastatic Hormone-Sensitive Prostate Cancer
    Brandon Bernard
    Christopher J. Sweeney
    Current Urology Reports, 2015, 16
  • [39] Management of Hormone-Sensitive Metastatic Prostate Cancer
    Agarwal, Neeraj
    Hussain, Maha
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1221 - +
  • [40] Update on Metastatic Hormone-Sensitive Prostate Cancer
    Chi, Kim N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 277 - 280
12345